JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Kunal Khanna and Mr. Dilip Singh Rathore as Other of the company w.e.f. March 05, 2026.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed the exchange that three senior management personnel have resigned effective March 5-6, 2026. Mr. Kunal Khanna stepped down as President – Operations, Mr. Dilip Singh Rathore as President (India Business), and Mr. Jason D'souza as Executive Vice President. The filing categorises these as a 'Change in Senior Management Personnel' under SEBI's Listing Regulations, with resignation letters enclosed. No reasons for the departures have been disclosed in the filing, and the company has not yet announced replacements.
Three senior leaders exiting in quick succession may create short-term uncertainty around operational and business continuity, though it could also reflect routine succession. Investors should watch for updates on replacements and any management commentary in the coming weeks.